With China’s continual rapid urbanization and industrialization, achieving energy efficiency and reducing CO2 emissions are urgent matters. With this commitment, Boehringer Ingelheim (BI) created BE GREEN initiatives in 2011, and further developed the concept to focus on environmental sustainability in 2020. The project managed to effectively improve energy efficiency and reduce CO2 emissions. The company adopted green energy, used green packaging, and created a green culture. This yielded many results including 98% of their pharmaceutical waste recycled, 25% less energy used since 2017 through smart cooling systems and LED light substitutes, and using water-based materials instead of UV lustering oil to be more eco-friendly. To move forward as a green pharmaceutical site, BI will continue to take action to relief the emission of Greenhouse gases by utilizing company’s BE Green Fund. The goal is to reduce BI’s environmental footprint by 2030 across the whole company by decreasing greenhouse gas emissions by 30 percent, relying on renewable energy for their electricity, and incorporating eco-design and green chemistry into their product development.

ESG Case

Alliance Leader

2021